Funder: Alzheimer's Drug Discovery Foundation
Due Dates: January 12, 2026 (Invited Full Proposal) | September 14, 2026 (Letter of Intent)
Funding Amounts: Up to $5,000,000 per project; multi-year funding; direct costs only.
Summary: Supports IND-enabling studies and early-phase clinical trials for innovative drugs and devices targeting Alzheimer's disease and related dementias.
Key Information: Academic, nonprofit, and biotech applicants worldwide eligible; anti-amyloid and cholinesterase inhibitor approaches are excluded.